|
|
 |
Resources - CCNE Kickoff Meeting
Webcast Event
November 18, 2005
The Centers of Cancer Nanotechnology Excellence (CCNEs) integrate nanotechnology development into basic and applied cancer research to facilitate rapid clinical application of advanced technologies. The Centers are the core units of the science and technology programs supported by the National Cancer Institute's Alliance for Nanotechnology in Cancer. Each CCNE functions as a consortia or network of laboratories and research facilities organized to address one or more of the six programmatic areas of emphasis identified in the Cancer Nanotechnology Plan as its focus for technology platform development: molecular imaging/early detection, in vivo imaging, reporters of efficacy, multifunctional therapeutics, prevention and control, and research enablers. Within the context of the specific areas of emphasis identified, the CCNEs offer the full range of support necessary to develop technologies and products suitable for clinical trial assessment, from fabrication and synthesis of nanomaterials, to combinatorial assembly of components (vectors, targeting agents, and biosensors) to pre-clinical testing with animal models. Each CCNE is working to develop and prototype nanotechnology platforms, each with discrete milestones and a dedicated research team.
|
|
